Flunixin meglumine accelerates uterine involution and shortens the calving-to-first-oestrus interval in cows with puerperal metritis

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2001, Pages 365-367

  Amiridis, G S ^a   Leontides, L ^a   Tassos, E ^a   Kostoulas, P ^a   Fthenakis, G C ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DUOPRIM; ENGEMYCIN; FLUNIXIN MEGLUMINE; OXYTETRACYCLINE; PROSTAGLANDIN E2; SULFADOXINE PLUS TRIMETHOPRIM; THROMBOXANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COW; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENDOTOXEMIA; ESTRUS; FEMALE; GREECE; INTRAUTERINE INFECTION; INVOLUTION; METRITIS; MILK PRODUCTION; NONHUMAN; PALPATION; PRIORITY JOURNAL; PUERPERAL DISORDER; RECTUM TEMPERATURE; SEXUAL BEHAVIOR; UTERUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; CATTLE DISEASES; CLONIXIN; ESTRUS; FEMALE; GREECE; PUERPERAL DISORDERS; TIME FACTORS; UTERINE DISEASES;

ANIMALIA;

EID: 0034772199     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00358.x     Document Type: Article

References (17)

1. Anti-inflammatory therapy in acute endotoxin-induced bovine mastitis
2. Short term changes in serum luteinizing hormone, ovarian response and reproductive performance following gonadotropin releasing hormone treatment in postpartum dairy cows with retained placenta
3. Endogenous opioid peptides in cattle during pregnancy, parturition and the neonatal period
4. Comparative study of the action of flunixin meglumine and tolfenamic acid on prostaglandin E2 synthesis in bovine inflamatory exudate
5. Reproductive traits of Holsteins and Jerseys: Effects of age, milk yield, and clinical abnormalities on involution of cervix and uterus, ovulation, estrus cycles, detection of estrus, conception rate and days open
6. Bovine endometritis: Current and future alternative therapy
7. Role of prostaglandins in uterine involution
8. Reproductive performance and problems
9. Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling
10. Postpartum ovarian activity and involution of the uterus and cervix in dairy cattle
11. The effect of intensive flunixin treatment during the postpartum period in the bovine
12. Effect of oral administration of flunixin meglumine on the inflammatory response to endotoxin in heifers
13. Ultrasonic observation of postpartum uterine involution in the cow
14. Uterine motility of cattle during late pregnancy, labor and puerperium. III. Use of flunixin meglumine and endocrine change (De)
15. Factors in the resumption of ovarian activity and uterine involution in postpartum dairy cows